If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...

Aria Manufacturing Limited, a full-service on-demand manufacturing partner serving clients across North America, Europe, and Asia, today announced it has crossed the ...

It's not even your browser's fault.

The design flaw in Flowise’s Custom MCP node has allowed attackers to execute arbitrary JavaScript through unvalidated ...

Nexus Pharmaceuticals, LLC announces the launch of Cyclophosphamide Injection, available in ready to dilute 2.5 mL fill and 5 ...

Threat actors can use malicious web content to set up AI Agent Traps and manipulate, deceive, and exploit visiting autonomous ...

A supply-chain attack backdoored versions of Axios, a popular JavaScript library that's present in many different software packages, to distribute a cross-platform, ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Peptides have become a buzzy wellness trend, promoted ...